Trial Profile
A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2016
Price :
$35
*
At a glance
- Drugs Udenafil (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Dong-A ST
- 16 Apr 2016 Results (n=18) published in the British Journal of Clinical Pharmacology.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2009 New trial record